Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto's thyroiditis

Clinical and Experimental Immunology

Volumn 180, Issue 1, 2015, Pages 58-69

  Kristensen, B ^a,c   Hegedus L ^c   Madsen, H O ^b   Smith, T J ^d   Nielsen, C H ^a  

^a Rigshospitalet   (Denmark)

^b University of Copenhagen   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Graves' disease; Hashimoto's thyroiditis; Interleukins; Regulatory T cells; Th17 cells

Indexed keywords

CD4 ANTIGEN; CD45R0 ANTIGEN; CD45RA ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; THYROGLOBULIN; THYROID PEROXIDASE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; AUTOANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; IODIDE PEROXIDASE; IRON BINDING PROTEIN; ISOPROTEIN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; TGFB1 PROTEIN, HUMAN; TPO PROTEIN, HUMAN;

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA SYNTHESIS; EXON; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HELPER CELL; HUMAN; MALE; MIDDLE AGED; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PURIFICATION; TH10 CELL; TH17 CELL; THYROTROPIN BLOOD LEVEL; AGED; ALTERNATIVE RNA SPLICING; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECTS; ESCHERICHIA COLI; IMMUNOLOGY; MULTICENTER STUDY; PATHOLOGY;

ADULT; AGED; ALTERNATIVE SPLICING; ANTIGENS, CD; AUTOANTIGENS; CELL DIFFERENTIATION; ESCHERICHIA COLI; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PROTEIN ISOFORMS; TH17 CELLS; THYROGLOBULIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84924333596     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12557     Document Type: Article

References (59)

1. Weetman AP. Determinants of autoimmune thyroid disease. Nat Immunol 2001; 2:769-770.
2. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-2357.
3. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173.
4. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-146.
5. Del Prete GF, Tiri A, Mariotti S, Pinchera A, Ricci M, Romagnani S. Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Clin Exp Immunol 1987; 69:323-331.
6. Guo J, Rapoport B, McLachlan SM. Balance of Th1/Th2 cytokines in thyroid autoantibody synthesis in vitro. Autoimmunity 1999; 30:1-9.
7. Ajjan RA, Watson PF, McIntosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol 1996; 105:523-528.
8. + T cells and B cells in the blood in health and autoimmune disease: increased frequency of thyroglobulin-reactive cells in Graves' disease. J Clin Immunol 2006; 26:126-137.
9. Colin IM, Isaac J, Dupret IP, Ledant T, D'Hautcourt JL. Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flow cytometric analysis of peripheral lymphocytes. J Biol Regul Homeost Agents 2004; 18:72-76.
10. Harrington LE, Hatton RD, Mangan PR etal. Interleukin-17 producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-1132.
11. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008; 223:87-113.
12. Kurts C. Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity. Nephrol Dial Transplant 2008; 23:816-819.
13. Shi Y, Wang H, Su Z etal. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand J Immunol 2010; 72:250-255.
14. Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 2009; 19:495-501.
15. Figueroa-Vega N, Alfonso-Perez M, Benedicto I, Sanchez-Madrid F, Gonzalez-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2010; 95:953-962.
16. Peng D, Xu B, Wang Y, Guo H, Jiang Y. A high frequency of circulating Th22 and Th17 cells in patients with new onset Graves' disease. PLOS ONE 2013; 8:e68446.
17. + regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun 2009; 33:68-76.
18. Marazuela M, Garcia-Lopez MA, Figueroa-Vega N etal. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 2006; 91:3639-3646.
19. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2006; 182:68-79.
20. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061.
21. + regulatory T cells. Nat Immunol 2003; 4:330-336.
22. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-1164.
23. +regulatory T cells by peripheral expansion. J Immunol 2004; 173:7259-7268.
24. + T cells with regulatory properties from human blood. J Exp Med 2001; 193:1303-1310.
25. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA 2003; 100:10878-10883.
26. Collison LW, Pillai MR, Chaturvedi V, Vignali DAA. Regulatory T cell suppression is potentiated by Target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 2009; 182:6121-6128.
27. Sundstedt A, Hoiden I, Rosendahl A, Kalland T, van Rooijen N, Dohlsten M. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol 1997; 158:180-186.
28. Glick AB, Wodzinski A, Pingfu F, Levine AD, Wald DN. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid 2013; 23:871-878.
29. Pan D, Shin YH, Gopalakrishnan G, Hennessey J, De Groot LJ. Regulatory T cells in Graves' disease. Clin Endocrinol (Oxf) 2009; 71:587-593.
30. Nielsen CH, Hegedus L, Rieneck K, Moeller AC, Leslie RGQ, Bendtzen K. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol 2007; 147:287-295.
31. + T cells from healthy donors to proliferate and promote production of the regulatory cytokine, interleukin-10, by monocytes. Immunology 2009; 129:291-299.
32. Langkjær A, Kristensen B, Hansen BF, Schultz H, Hegedus L, Nielsen CH. B-cell exposure to self-antigen induces IL-10 producing B cells as well as IL-6 and TNF-α producing B-cell subsets in healthy humans. Clin Immunol 2012; 145:1-10.
33. Yang L, Anderson DE, Baecher-Allan C etal. IL-21 and TGF-beta are required for differentiation of human T(H)17 cell. Nature 2008; 454:350-352.
34. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:942-949.
35. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammaT. Nat Immunol 2008; 9:641-649.
36. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-189.
37. Bettelli E, Carrier Y, Gao W etal. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006; 441:235-238.
38. Ayyoub M, Deknuydt F, Raimbaud I etal. Human memory FOXP3 Tregs secrete IL-17 ex vivo and constitutively express the Th17 lineage-specific transcription factor RORgammaT. Proc Natl Acad Sci USA 2009; 106:8635-8640.
39. + regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112:2340-2352.
40. Beriou G, Costantino CM, Ashley CW etal. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113:4240-4249.
41. Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008; 31:252-256.
42. McGreachy MJ, Bak-Jensen KS, Chen Y etal. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat Immunol 2007; 8:1390-1397.
43. Zielinski CE, Mele F, Aschenbrenner D etal. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012; 484:514-519.
44. Hedegaard CJ, Krakauer M, Bendtzen K, Lund H, Sellebjerg F, Nielsen CH. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology 2008; 125:161-169.
45. Lui S, Tobias R, McClure S, Styba G, Shi Q, Jackowski G. Removal of endotoxin from protein preparations. Clin Biochem 1997; 30:455-463.
46. Ryder LR, Woetmann A, Madsen HO etal. Expression of full-length and splice forms of FOXP3 in rheumatoid arthritis. Scand J Rheumatol 2010; 39:279-286.
47. + T cells in rheumatoid arthritis and psoriatic arthritis. APMIS 2011; 120:387-396.
48. Mane VP, Heuer MA, Hillyer P, Navarro MB, Rabin RL. Systematic method for determining an ideal housekeeping gene for real-time PCR analysis. J Biomol Tech 2008; 19:342-347.
49. McAleer JP, Liu B, Li Z etal. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J Leukoc Biol 2010; 88:21-31.
50. Kobayashi I, Shiari R, Yamada M etal. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet 2001; 38:874-876.
51. Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007; 120:744-750.
52. Krejsgaard T, Gjerdrum LM, Ralfkiaer E etal. Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome. Leukemia 2008; 22:2230-2239.
53. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 2005; 102:5138-5143.
54. Du J, Huang C, Zhou B, Ziegler SF. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J Immunol 2008; 180:4785-4792.
55. Zhou L, Lopes JE, Chong MM etal. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453:236-240.
56. McGregor MA, Petersen MM, McLachlan SM, Rooke P, Rees Smith B, Hall R. Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 1980; 303:302-307.
57. Weiss I, Davis TF. Inhibition of immunoglobulin-secreting cells by antithyroid cells. J Clin Endocrinol Metab 1981; 53:1223-1228.
58. Humar M, Dohrmann H, Stein P etal. Thionamides inhibit the transcription factor nuclear factor-κB by suppression of Rac1 and inhibitor of κB kinase α. J Pharmacol Exp Ther 2008; 324:1037-1044.
59. Volpe R. The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signaling: a review. Curr Pharm Des 2001; 7:451-460.